Lanssjukhuset Ryhov Onkologiska kliniken

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Melanoma

Running trials

• Recruiting

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· Phase 3· Immunocore Ltd· Source

  Contact: Bo Thelin

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Melanoma1 recruiting